Ammonia N-13 now available at virtually any medical facility
Ionetix Corporation is a pioneering radiopharmaceutical end to end solutions provider for cardiac PET. We are changing the paradigm when it comes to access to one of the most accurate PET imaging agents for the detection of coronary artery disease, Ammonia N-13. Until now, this radiopharmaceutical was only available to a select group of institutions due to its very short half-life and the need for a large and expensive cyclotron on site. Ionetix can now provide virtually any hospital or private center with on demand Ammonia N-13 doses without the need to purchase a cyclotron!
Download Info Packet
Presented at the ASNC 2019 by the University of Michigan
“N13-ammonia produced by the Ionetix ION-12SC delivered high quality myocardial PET perfusion images in a safe and reliable manner with a rapid protocol.”